author-photo

E. Petricoin

George Mason University

20

Papers

208

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

2021 Cancer Cell
Show All
- Source
- Cite
- Save
Citations (5)
Defining the KRAS-regulated kinome in KRAS-mutant pancreatic cancer

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Durvalumab With Olaparib and Paclitaxel for High-Risk HER2-Negative Stage II/III Breast Cancer: Results From the Adaptively Randomized I-SPY2 Platform Trial

2020
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT3-02-06: Utilizing multiomic advanced diagnostics to identify CDK4/6 inhibitor response predictors and a post-treatment multiomic signature for patients with ER+/HER2- metastatic breast cancer (SIDEOUT-3)

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P3-10-02: Identifying breast cancer molecular phenotypes to predict response in a modern treatment landscape: Lessons from ˜1000 patients across 10 arms of the I-SPY 2 TRIAL

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma.

2018 Nature Genetics
Show All
- Source
- Cite
- Save
Citations (24)
430PPhase I study: Safety and tolerability of varlitinib (VAR) in combination with oxaliplatin and capecitabine (COX) or oxaliplatin and 5-FU (FOL) in advanced solid tumours

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Use of a prognostic pathway signature for colorectal cancer comprised of EGFR/COX2 and imatinib drug target activation to predict occult metastasis in M0 CRC

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation.

2016 Oncogene
Show All
- Source
- Cite
- Save
Citations (24)
Inhibition of Akt enhances the chemopreventive effects of topical rapamycin in mouse skin

2016 Cancer Prevention Research
Show All
- Source
- Cite
- Save
Citations (13)